Back to Results
First PageMeta Content
Oppenheimer / Finance / Short / Investment / Oppenheimer Holdings / Financial economics


Document Date: 2013-12-03 09:36:21

Open Document

File Size: 429,85 KB

Share Result on Facebook

City

New York / /

Company

Investment Thesis Pluristem Therapeutics Inc. / BlueMatrix 0 Pluristem Therapeutics Inc. / Certifications / Oppenheimer & Co. Inc. / SUMMARY Yesterday Aastrom Biosciences / Pluristem Therapeutics Inc. / Additionally / Oppenheimer & Co. Inc. / /

Continent

Europe / /

Country

United States / /

Currency

USD / /

/

Event

FDA Phase / Dividend Issuance / Analyst Recommendation / /

/

IndustryTerm

regenerative applications / biotechnology / retail / stage biotechnology company developing placental stem cells / banking / pharmaceutical techniques / healthcare / retail investors / /

MarketIndex

S&P 500 / /

MedicalCondition

Peripheral Artery Disease / local and systemic inflammatory diseases / /

MedicalTreatment

amputation / stem cell therapies / cell therapy / /

Organization

EMA / FDA / FINRA / /

Person

Boris Peaker / ROE LT / /

/

Position

author / Business Manager / advisor / board member / officer / director / physician / Analyst / adviser / /

Product

Phase II / Pluristem / /

ProvinceOrState

New York / /

Technology

drug delivery / cell therapy / BIOTECHNOLOGY / stem cells / /

URL

http /

SocialTag